Wanbangde Pharmaceutical Holding Group Co Ltd Net Asset Momentum
Wanbangde Pharmaceutical Holding Group Co Ltd net asset momentum. Wanbangde Pharmaceutical Holding Group Co Ltd (002082) recorded a net asset momentum of -5.4% as of December 2025, with net assets of CN¥2.61 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is Wanbangde Pharmaceutical Holding Group C's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Net asset momentum of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025. This chart tracks Wanbangde Pharmaceutical Holding Group Co Ltd's year-over-year net asset growth across 23 annual reporting periods from 2003 to 2025. The most recent momentum reading is -5.4%, with net assets of CN¥2.61 Billion CNY as of December 2025. Check 002082 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Wanbangde Pharmaceutical Holding Group Co Ltd Net Asset Momentum by Year (2003–2025)
Wanbangde Pharmaceutical Holding Group Co Ltd net asset momentum by year from 2003 to 2025. The table below shows the complete annual net asset history for Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025, covering 23 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 002082 market cap.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥2.61 Billion | CN¥4.39 Billion | CN¥1.78 Billion | ▼ -5.4% |
| 2024 | CN¥2.76 Billion | CN¥4.33 Billion | CN¥1.57 Billion | ▼ -0.1% |
| 2023 | CN¥2.76 Billion | CN¥4.30 Billion | CN¥1.54 Billion | ▼ -2.1% |
| 2022 | CN¥2.82 Billion | CN¥4.22 Billion | CN¥1.40 Billion | ▲ +2.7% |
| 2021 | CN¥2.74 Billion | CN¥4.37 Billion | CN¥1.63 Billion | ▼ -4.0% |
| 2020 | CN¥2.86 Billion | CN¥5.66 Billion | CN¥2.80 Billion | ▲ +49.5% |
| 2019 | CN¥1.91 Billion | CN¥3.80 Billion | CN¥1.89 Billion | ▲ +10.9% |
| 2018 | CN¥1.72 Billion | CN¥2.85 Billion | CN¥1.12 Billion | ▲ +7.5% |
| 2017 | CN¥1.60 Billion | CN¥2.10 Billion | CN¥496.58 Million | ▲ +14.8% |
| 2016 | CN¥1.40 Billion | CN¥1.66 Billion | CN¥261.85 Million | ▲ +3.7% |
| 2015 | CN¥1.35 Billion | CN¥1.62 Billion | CN¥270.28 Million | ▲ +3.9% |
| 2014 | CN¥1.30 Billion | CN¥1.55 Billion | CN¥254.69 Million | ▲ +9.1% |
| 2013 | CN¥1.19 Billion | CN¥1.55 Billion | CN¥361.07 Million | ▲ +8.2% |
| 2012 | CN¥1.10 Billion | CN¥1.57 Billion | CN¥469.09 Million | ▲ +4.1% |
| 2011 | CN¥1.05 Billion | CN¥1.45 Billion | CN¥392.22 Million | ▲ +12.6% |
| 2010 | CN¥936.13 Million | CN¥1.32 Billion | CN¥380.46 Million | ▲ +15.3% |
| 2009 | CN¥811.59 Million | CN¥1.12 Billion | CN¥307.39 Million | ▲ +13.9% |
| 2008 | CN¥712.31 Million | CN¥1.02 Billion | CN¥309.46 Million | ▲ +71.6% |
| 2007 | CN¥415.12 Million | CN¥927.63 Million | CN¥512.51 Million | ▲ +16.0% |
| 2006 | CN¥357.72 Million | CN¥851.57 Million | CN¥493.85 Million | ▲ +134.0% |
| 2005 | CN¥152.88 Million | CN¥661.73 Million | CN¥508.84 Million | ▲ +12.3% |
| 2004 | CN¥136.17 Million | CN¥416.66 Million | CN¥280.48 Million | ▲ +38.2% |
| 2003 | CN¥98.53 Million | CN¥261.57 Million | CN¥163.05 Million | — |